Mortality Attributable to Smoking Among HIV-1–Infected Individuals: A Nationwide, Population-Based Cohort Study
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
BACKGROUND: We assessed mortality attributable to smoking among patients with human immunodeficiency virus (HIV). METHODS: We estimated mortality rates (MRs), mortality rate ratios (MRRs), life expectancies, life-years lost, and population-attributable risk of death associated with smoking and with HIV among current and nonsmoking individuals from a population-based, nationwide HIV cohort and a cohort of matched HIV-negative individuals. RESULTS: A total of 2921 HIV patients and 10 642 controls were followed for 14 281 and 45 122 person-years, respectively. All-cause and non-AIDS-related mortality was substantially increased among smoking compared to nonsmoking HIV patients (MRR, 4.4 [95% confidence interval {CI}, 3.0-6.7] and 5.3 [95% CI, 3.2-8.8], respectively). Excess MR per 1000 person-years among current vs nonsmokers was 17.6 (95% CI, 13.3-21.9) for HIV patients and 4.8 (95% CI, 3.2-6.4) for controls. A 35-year-old HIV patient had a median life expectancy of 62.6 years (95% CI, 59.9-64.6) for smokers and 78.4 years (95% CI, 70.8-84.0) for nonsmokers; the numbers of life-years lost in association with smoking and HIV were 12.3 (95% CI, 8.1-16.4) and 5.1 (95% CI, 1.6-8.5). The population-attributable risk of death associated with smoking was 61.5% among HIV patients and 34.2% among controls. CONCLUSIONS: In a setting where HIV care is well organized and antiretroviral therapy is free of charge, HIV-infected smokers lose more life-years to smoking than to HIV. The excess mortality of smokers is tripled and the population-attributable risk of death associated with smoking is doubled among HIV patients compared to the background population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PLWH who smoke (SLWH) lose more life-years than PLWH who do not smoke and people who smoke who do not have HIV.3–5”
In the citing paper
“Indeed, a recent cohort study found that life-years lost among SLWH (12.3) was nearly quadruple that of HIV-negative individuals who smoked (3.6) and more than double PLWH who did not smoke (5.1).3”
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
International Statistical Classification of Diseases and Related Health Problems
Eisfeld, J. (2014) · TSQ: Transgender Studies Quarterly · doi:10.1215/23289252-2399740 · Cited by 3,570
International Statistical Classification of Diseases and Related Health Problems 10th Revision
(2013) · A Companion to the Classification of Mental Disorders · doi:10.1093/med/9780199669493.005.0005 · Cited by 2,059
Genetically elevated C-reactive protein and ischemic vascular disease
Zacho, J., Tybjærg-Hansen, A., Jensen, J. S., Grande, P., Sillesen, H., & Nordestgaard, B. G. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707402 · Cited by 839 · cited 1×
“The Copenhagen General Population Study is a prospective study of a cohort of individuals randomly selected from greater Copenhagen [9–11].”
BackgroundSelf-citationMorbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study
Hasse, B., Ledergerber, B., Furrer, H., Battegay, M., Hirschel, B., Cavassini, M., Bertisch, B., Bernasconi, E., Weber, R., & Study, T. S. H. C. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir626 · Cited by 608
SMOKING AND DEATH RATES—REPORT ON FORTY-FOUR MONTHS OF FOLLOW-UP OF 187,783 MEN
Hammond, E. C. (1958) · Journal of the American Medical Association · doi:10.1001/jama.1958.02990110030007 · Cited by 563
Sackoff, J. E., Hanna, D. B., Pfeiffer, M. R., & Torian, L. V. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-6-200609190-00003 · Cited by 451
The Danish registers of causes of death.
Juel, K., & Helweg‐Larsen, K. (1999) · PubMed · Cited by 411
May, M., Gompels, M., Delpech, V., Porter, K., Post, F., Johnson, M., Dunn, D., Palfreeman, A., Gilson, R., Gazzard, B., et al. (2011) · BMJ · doi:10.1136/bmj.d6016 · Cited by 363 · cited 1×
“for long-term mortality rather than the period shortly after diagnosis where the prognosis is closely associated with the immune status at the time of presentation [31, 32].”
BackgroundStringhini, S., Dugravot, A., Shipley, M., Goldberg, M., Zins, M., Kivimäki, M., Marmot, M., Sabia, S., & Singh-Manoux, A. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000419 · Cited by 357
Research works printed but not linked: 1
- The Central Office of Civil Registration, The Civil Registration System in Denmark
Cited by
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784
“Smoking increases mortality even in the presence of maximal viral suppression.(606) Furthermore, among HIV-infected individuals, the prevalence of dyslipidemia, diabetes mellitus, and hypertension is higher than in the general population.”
BackgroundMay, M. T., Gompels, M., Delpech, V., Porter, K., Orkin, C., Kegg, S., Hay, P., Johnson, M., Palfreeman, A., Gilson, R., et al. (2014) · AIDS · doi:10.1097/qad.0000000000000243 · Cited by 593
Mdodo, R., Frazier, E. L., Dube, S. R., Mattson, C. L., Sutton, M. Y., Brooks, J. T., & Skarbinski, J. (2015) · Annals of Internal Medicine · doi:10.7326/m14-0954 · Cited by 455
Helleberg, M., May, M. T., Ingle, S. M., Dabis, F., Reiss, P., Fätkenheuer, G., Costagliola, D., d’Arminio, A., Cavassini, M., Smith, C., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000540 · Cited by 268
Self-citationFeldman, C., & Anderson, R. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.05.004 · Cited by 242
Schmidt, A. J., Bourne, A., Weatherburn, P., Reid, D., Marcus, U., & Hickson, F. (2016) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2016.09.007 · Cited by 240
Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges
Rubinstein, P. G., Aboulafia, D. M., & Zloza, A. (2014) · AIDS · doi:10.1097/qad.0000000000000071 · Cited by 237
Cardiovascular Disease and HIV Infection
Triant, V. A. (2013) · Current HIV/AIDS Reports · doi:10.1007/s11904-013-0168-6 · Cited by 236
Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection
Triant, V. A., Perez, J., Regan, S., Massaro, J. M., Meigs, J. B., Grinspoon, S. K., & D’Agostino, R. B. (2018) · Circulation · doi:10.1161/circulationaha.117.028975 · Cited by 235
HIV infection and coronary heart disease: mechanisms and management
Hsue, P. Y., & Waters, D. D. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0219-9 · Cited by 229
Rasmussen, L. D., May, M. T., Kronborg, G., Larsen, C. S., Pedersen, C., Gerstoft, J., & Obel, N. (2015) · The Lancet HIV · doi:10.1016/s2352-3018(15)00077-6 · Cited by 201
Self-citationSabin, C. A. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-251 · Cited by 179
Pathogenesis of HIV-Related Lung Disease: Immunity, Infection, and Inflammation
Cribbs, S. K., Crothers, K., & Morris, A. (2020) · Physiological Reviews · doi:10.1152/physrev.00039.2018 · Cited by 173
Cardiovascular risk and dyslipidemia among persons living with HIV: a review
Maggi, P., Biagio, A. D., Rusconi, S., Cicalini, S., D’Abbraccio, M., d’Ettorre, G., Martinelli, C. V., Nunnari, G., Sighinolfi, L., Spagnuolo, V., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2626-z · Cited by 168
Rasmussen, L. D., Helleberg, M., May, M. T., Afzal, S., Kronborg, G., Larsen, C. S., Pedersen, C., Gerstoft, J., Nordestgaard, B. G., & Obel, N. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ013 · Cited by 141
Self-citationSmoking and HIV: Prevalence, Health Risks, and Cessation Strategies
Lifson, A. R., & Lando, H. A. (2012) · Current HIV/AIDS Reports · doi:10.1007/s11904-012-0121-0 · Cited by 142
Mdege, N. D., Shah, S., Ayo-Yusuf, O. A., Hakim, J. G., & Siddiqi, K. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30170-5 · Cited by 141
Expert consensus statement on the science of HIV in the context of criminal law
Barré‐Sinoussi, F., Karim, S. S. A., Albert, J., Bekker, L., Beyrer, C., Cahn, P. E., Calmy, A., Grinsztejn, B. G. J., Grulich, A. E., Kamarulzaman, A., et al. (2018) · Journal of the International AIDS Society · doi:10.1002/jia2.25161 · Cited by 138
Reddy, K. P., Kong, C. Y., Hyle, E. P., Baggett, T. P., Huang, M., Parker, R. A., Paltiel, A. D., Losina, E., Weinstein, M. C., Freedberg, K. A., et al. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.4349 · Cited by 136
Reddy, K. P., Parker, R. A., Losina, E., Baggett, T. P., Paltiel, A. D., Rigotti, N. A., Weinstein, M. C., Freedberg, K. A., & Walensky, R. P. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw430 · Cited by 135
Patterns of drug use and HIV infection among adults in a nationally representative sample
Shiau, S., Arpadi, S. M., Yin, M. T., & Martins, S. S. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.01.015 · Cited by 127
Basha, N. J., & Goudgaon, N. M. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.131168 · Cited by 127
Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers
Lagathu, C., Cossarizza, A., Béréziat, V., Nasi, M., Capeau, J., & Pinti, M. (2017) · AIDS · doi:10.1097/qad.0000000000001441 · Cited by 110
Valiathan, R., Míguez, M. J., Patel, B., Arheart, K. L., & Asthana, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097698 · Cited by 121
Drug–drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems
Kumar, S., Rao, P., Earla, R., & Kumar, A. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.996546 · Cited by 116
Lung cancer in persons with HIV
Sigel, K. M., Makinson, A., & Thaler, J. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000326 · Cited by 120
Risk of coronary heart disease in patients with HIV infection
Zanni, M. V., Schouten, J., Grinspoon, S. K., & Reiss, P. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.167 · Cited by 117
Zanet, D. L., Thorne, A., Singer, J., Maan, E. J., Sattha, B., Campion, A. L., Soudeyns, H., Pick, N., Murray, M. C. M., Money, D., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu051 · Cited by 117
Pacek, L. R., McClernon, F. J., & Bosworth, H. B. (2017) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntx210 · Cited by 115
Helleberg, M., Gerstoft, J., Afzal, S., Kronborg, G., Larsen, C. S., Pedersen, C., Bojesen, S. E., Nordestgaard, B. G., & Obel, N. (2014) · AIDS · doi:10.1097/qad.0000000000000283 · Cited by 114
Self-citationUpdate of Survival for Persons With HIV Infection in Denmark
Lohse, N., & Obel, N. (2016) · Annals of Internal Medicine · doi:10.7326/l16-0091 · Cited by 114
Self-citationInterventions for tobacco use cessation in people living with HIV and AIDS
Pool, E. R., Dogar, O., Lindsay, R. P., Weatherburn, P., & Siddiqi, K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011120.pub2 · Cited by 106
Hsu, D. C., & Sereti, I. (2016) · Drugs · doi:10.1007/s40265-016-0546-7 · Cited by 112
Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
Reid, E. G., Suneja, G., Ambinder, R. F., Ard, K. L., Baiocchi, R. A., Barta, S. K., Carchman, E. H., Cohen, A. L., Gupta, N. K., Johung, K. L., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0066 · Cited by 112
Population-Based Estimates of Life Expectancy After HIV Diagnosis: United States 2008–2011
Siddiqi, A.-E.-A., Hall, H. I., Hu, X., & Song, R. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000960 · Cited by 107
Exploring Issues of Comorbid Conditions in People Who Smoke: Table 1.
Rojewski, A. M., Baldassarri, S. R., Cooperman, N. A., Gritz, E. R., Leone, F. T., Piper, M. E., Toll, B. A., & Warren, G. W. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw016 · Cited by 92
Lipid Abnormalities in Persons Living With HIV Infection
Waters, D. D., & Hsue, P. Y. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.11.005 · Cited by 90
Long-term outcomes of a cell phone–delivered intervention for smokers living with HIV/AIDS
Gritz, E. R., Danysh, H. E., Fletcher, F. E., Tami-Maury, I., Fingeret, M. C., King, R. M., Arduino, R. C., & Vidrine, D. J. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit349 · Cited by 89
Gabuzda, D. H., Jamieson, B. D., Collman, R. G., Lederman, M. M., Burdo, T. H., Deeks, S. G., Dittmer, D. P., Fox, H. S., Funderburg, N., Pahwa, S. G., et al. (2020) · Pathogens and Immunity · doi:10.20411/pai.v5i1.365 · Cited by 89
Effects of Smoking on Non-AIDS-Related Morbidity in HIV-Infected Patients
Shirley, D. K., Kaner, R. J., & Glesby, M. J. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit207 · Cited by 88
O’Cleirigh, C., Valentine, S. E., Pinkston, M., Herman, D., Bedoya, C. A., Gordon, J. R., & Safren, S. A. (2015) · AIDS and Behavior · doi:10.1007/s10461-014-0762-7 · Cited by 87
“2 % among demographically matched HIVnegative controls [17].”
Hyle, E. P., Mayosi, B. M., Middelkoop, K., Mosepele, M., Martey, E. B., Walensky, R. P., Bekker, L., & Triant, V. A. (2017) · BMC Public Health · doi:10.1186/s12889-017-4940-1 · Cited by 86
Elvstam, O., Marrone, G., Medstrand, P., Treutiger, C. J., Sönnerborg, A. B., Gisslén, M., & Björkman, P. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa413 · Cited by 85
Asfar, T., Perez, A., Shipman, P., Carrico, A. W., Lee, D. J., Alcaide, M. L., Jones, D. L., Brewer, J. A., & Koru‐Sengul, T. (2021) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaa277 · Cited by 83
Kourí, V., Khouri, R., Alemán, Y., Abrahantes, Y., Vercauteren, J., Pineda-Peña, A.-C., Theys, K., Megens, S., Moutschen, M. P., Pfeifer, N., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.01.015 · Cited by 83
Fontela, C., Aguinaga, A., Moreno‐Iribas, C., Repáraz, J., Rivero, M., Gracia, M., Floristán, Y., Fresán, U., Miguel, R. S., Ezpeleta, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-65841-0 · Cited by 80
Serious Non-AIDS events: Immunopathogenesis and interventional strategies
Hsu, D. C., Sereti, I., & Ananworanich, J. (2013) · AIDS Research and Therapy · doi:10.1186/1742-6405-10-29 · Cited by 80
Hema, M. N., Ferry, T., Dupon, M., Cuzin, L., Verdon, R., Thiébaut, R., Protopopescu, C., Leport, C., Raffi, F., Moing, V. L., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161594 · Cited by 80
Worldwide relative smoking prevalence among people living with and without HIV
Johnston, P. I., Wright, S. W., Orr, M., Pearce, F., Stevens, J., Hubbard, R., & Collini, P. (2021) · AIDS · doi:10.1097/qad.0000000000002815 · Cited by 79
Mani, D., Haigentz, M., & Aboulafia, D. M. (2011) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.05.005 · Cited by 78
Smoking, alcohol and illicit drug use effects on survival in HIV-positive persons
Petoumenos, K., & Law, M. G. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000306 · Cited by 78
Tobacco Use, Use Disorders, and Smoking Cessation Interventions in Persons Living With HIV
Pacek, L. R., & Cioe, P. A. (2015) · Current HIV/AIDS Reports · doi:10.1007/s11904-015-0281-9 · Cited by 78
Ssewanyana, D., Mwangala, P. N., van Baar, A. L., Newton, C. R. J. C., & Abubakar, A. A. (2018) · BioMed Research International · doi:10.1155/2018/7375831 · Cited by 78
AIDS-Related Kaposi Sarcoma, Version 2.2019
Reid, E. G., Suneja, G., Ambinder, R. F., Ard, K. L., Baiocchi, R. A., Barta, S. K., Carchman, E. H., Cohen, A. K., Crysler, O., Gupta, N. K., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0008 · Cited by 78
Cancer prevention in HIV-infected populations
Goncalves, P. H., Montezuma-Rusca, J. M., Yarchoan, R., & Uldrick, T. S. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.09.011 · Cited by 77
Risk of Cardiovascular Disease in an Aging HIV Population: Where Are We Now?
Martín-Iguacel, R., Llibre, J. M., & Friis‐Møller, N. (2015) · Current HIV/AIDS Reports · doi:10.1007/s11904-015-0284-6 · Cited by 76
Tobacco, illicit drugs use and risk of cardiovascular disease in patients living with HIV
Raposeiras‐Roubín, S., Abu-Assi, E., & Íñiguez, A. (2017) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000407 · Cited by 74
Thompson‐Paul, A. M., Wei, S. C., Mattson, C. L., Robertson, M. M., Hernandez‐Romieu, A. C., Bell, T. K., & Skarbinski, J. (2015) · Medicine · doi:10.1097/md.0000000000001081 · Cited by 74
Holmes, C. B., Sikazwe, I. T., Sikombe, K., Eshun‐Wilson, I., Czaicki, N. L., Beres, L. K., Mukamba, N., Simbeza, S., Bolton‐Moore, C., Hantuba, C., et al. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002489 · Cited by 73
Louwagie, G. M. C., Okuyemi, K. S., & Ayo‐Yusuf, O. A. (2014) · Addiction · doi:10.1111/add.12671 · Cited by 72
Cigarette smoking and drug use among a nationally representative sample of HIV-positive individuals
Pacek, L. R., Harrell, P. T., & Martins, S. S. (2014) · American Journal on Addictions · doi:10.1111/j.1521-0391.2014.12145.x · Cited by 72
Decreased Lung Function and All-Cause Mortality in HIV-infected Individuals
Gingo, M. R., Nouraie, M. S., Kessinger, C. J., Greenblatt, R. M., Huang, L., Kleerup, E. C., Kingsley, L., McMahon, D. K., & Morris, A. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201606-492oc · Cited by 73
Cardiovascular disease risk among women living with HIV in North America and Europe
Stone, L. A., Looby, S. E. D., & Zanni, M. V. (2017) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000413 · Cited by 68
Smoking-Cessation Interventions in People Living With HIV Infection: A Systematic Review
Moscou-Jackson, G., Commodore-Mensah, Y. Y., Farley, J. E., & DiGiacomo, M. L. (2013) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2013.04.005 · Cited by 67
Mutoh, Y., Nishijima, T., Inaba, Y., Tanaka, N., Kikuchi, Y., Gatanaga, H., & Oka, S. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy176 · Cited by 67
Substance Use Among Older People Living With HIV: Challenges for Health Care Providers
Deren, S., Cortes, T., Dickson, V. V., Guilamo‐Ramos, V., Han, B. H., Karpiak, S. E., Naegle, M. A., Ompad, D. C., & Wu, B. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00094 · Cited by 66
Pulmonary Immune Dysregulation and Viral Persistence During HIV Infection
Alexandrova, Y., Costiniuk, C. T., & Jenabian, M.-A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.808722 · Cited by 65
Hile, S. J., Feldman, M. B., Alexy, E. R., & Irvine, M. K. (2016) · AIDS and Behavior · doi:10.1007/s10461-015-1273-x · Cited by 64
Edwards, J. K., Cole, S. R., Breger, T. L., Rudolph, J. E., Filiatreau, L. M., Buchacz, K. A., Humes, E., Rebeiro, P. F., DʼSouza, G., Gill, M. J., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m21-0065 · Cited by 64
Tron, L., Lert, F., Spire, B., Dray‐Spira, R., & the ANRS-Vespa2 study group (2014) · PLoS ONE · doi:10.1371/journal.pone.0107451 · Cited by 64
Konstantinidis, I., Crothers, K. A., Kunisaki, K. M., Drummond, M., Benfield, T., Zar, H. J., Huang, L., & Morris, A. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00450-5 · Cited by 61
Smoking and HIV in Sub-Saharan Africa: A 25-Country Analysis of the Demographic Health Surveys
Murphy, J. D., Liu, B., & Parascandola, M. J. (2018) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty176 · Cited by 59
Substance use in older HIV-infected patients
Edelman, E. J., Tetrault, J. M., & Fiellin, D. A. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000069 · Cited by 59
Cohort Profile Update: The Danish HIV Cohort Study (DHCS)
Omland, L. H., Ahlström, M. G., & Obel, N. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu153 · Cited by 53
Self-citationCardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk?
Shahbaz, S., Manicardi, M., Guaraldi, G., & Raggi, P. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i10.633 · Cited by 55
Determinants of Smoking and Quitting in HIV-Infected Individuals
Regan, S., Meigs, J. B., Grinspoon, S. K., & Triant, V. A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153103 · Cited by 51
Uriel, N. Y., Nahumi, N., Colombo, P. C., Yuzefpolskaya, M., Restaino, S. W., Han, J. J., Thomas, S. S., Garan, A. R., Takayama, H., MANCINI, D. M., et al. (2014) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.04.015 · Cited by 55
Brain arterial remodeling contribution to nonembolic brain infarcts in patients with HIV
Gutierrez, J., Goldman, J. E., Dwork, A. J., Elkind, M. S. V., Marshall, R. S., & Morgello, S. (2015) · Neurology · doi:10.1212/wnl.0000000000001976 · Cited by 54
Effects of tobacco smoking on HIV-infected individuals.
Calvo, M., Laguno, M., Martínez, M., & Martínez, E. (2015) · PubMed · Cited by 54
Weinberger, A. H., Smith, P. H., Funk, A. P., Rabin, S., & Shuter, J. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001279 · Cited by 51
Gesesew, H. A., Ward, P., Hajito, K. W., Feyissa, G. T., Mohammadi, L., & Mwanri, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169651 · Cited by 53
Tobacco smoking effect on HIV-1 pathogenesis: role of cytochrome P450 isozymes
Ande, A., McArthur, C. P., Kumar, A., & Kumar, S. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.816285 · Cited by 53
Bruyand, M., Ryom, L., Shepherd, L. C., Fätkenheuer, G., Grulich, A. E., Reiss, P., Wit, S. D., Monforte, A. D., Furrer, H., Pradier, C., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000523 · Cited by 52
Cardiovascular Complications of HIV in Endemic Countries
Feinstein, M. J., Bogorodskaya, M., Bloomfield, G. S., Vedanthan, R., Siedner, M. J., Kwan, G. F., & Longenecker, C. T. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0794-x · Cited by 52
Ashare, R. L., Thompson, M., Serrano, K., Leone, F. T., Metzger, D. S., Frank, I., Gross, R., Hole, A. V., Mounzer, K., Collman, R. G., et al. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.03.011 · Cited by 53
Shuter, J., Morales, D. A., Considine-Dunn, S. E., An, L. C., & Stanton, C. A. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000226 · Cited by 51
“One recent study concluded that 61% of deaths in PLWH were directly attributable to smoking, and that smoking reduced longevity by an average of 12 years.(3) Smoking increases the risk of both opportunistic and “typical” infections in PLWH.”
BackgroundSmoking and HIV: what are the risks and what harm reduction strategies do we have at our disposal?
Giles, M., GARTNER, C. E., & Boyd, M. A. (2018) · AIDS Research and Therapy · doi:10.1186/s12981-018-0213-z · Cited by 51
COPD in HIV-Infected Patients: CD4 Cell Count Highly Correlated
Risso, K., Salvador-Guillouët, F. D., Valério, L., Puglièse, P., Naqvi, A., Durant, J., Demonchy, É., Perbost, I., Cua, É., Marquette, C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169359 · Cited by 51
Petoumenos, K., Huang, R., Hoy, J., Bloch, M. T., Templeton, D. J., Baker, D. A., Giles, M., Law, M. G., & Cooper, D. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184583 · Cited by 51
Human Immunodeficiency Virus–Associated Obstructive Lung Diseases
Gingo, M. R., Morris, A., & Crothers, K. A. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.02.002 · Cited by 50
Kodidela, S., Wang, Y., Patters, B. J., Gong, Y., Sinha, N., Ranjit, S., Gerth, K. A., Haque, S., Cory, T. J., McArthur, C. P., et al. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09853-2 · Cited by 48
Nichols, S., Lowe, A., Zhang, X., Garvie, P. A., Thornton, S., Goldberger, B. A., Hou, W., Goodenow, M. M., & Sleasman, J. W. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.11.010 · Cited by 48
Epidemiology of ischemic heart disease in HIV
Triant, V. A., & Grinspoon, S. K. (2017) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000410 · Cited by 47
Causes of death in HIV-infected patients from the Cologne–Bonn cohort
Ehren, K., Hertenstein, C., Kümmerle, T., Vehreschild, J. J., Fischer, J., Gillor, D., Wyen, C., Lehmann, C., Cornely, O. A., Jung, N., et al. (2013) · Infection · doi:10.1007/s15010-013-0535-7 · Cited by 46
Cigarette Smokers are Less Likely to Have Undetectable Viral Loads: Results From Four HIV Clinics
Cropsey, K. L., Willig, J. H., Mugavero, M. J., Crane, H. M., McCullumsmith, C. B., Lawrence, S. T., Raper, J. L., Mathews, W. C., Boswell, S., Kitahata, M. M., et al. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000172 · Cited by 46
Impact of HIV infection and smoking on lung immunity and related disorders
Rossouw, T. M., Anderson, R., & Feldman, C. H. (2015) · European Respiratory Journal · doi:10.1183/13993003.00353-2015 · Cited by 45
Carter, A., Roth, E. A., Ding, E., Milloy, M., Kestler, M., Jabbari, S., Webster, K., de Pokomandy, A., Loutfy, M. R., & Kaida, A. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1863-x · Cited by 45
Differences in the rate of nicotine metabolism among smokers with and without HIV
Ashare, R. L., Thompson, M., Leone, F. T., Metzger, D. E., Gross, R., Mounzer, K., Tyndale, R. F., Lerman, C. E., Mahoney, M. C., Cinciripini, P. M., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002127 · Cited by 45
Nguyen, N. P. T., Tran, B. X., Hwang, L. Y., Markham, C. M., Swartz, M. D., Phan, H. T. T., Nong, V. M., Nguyen, C. T., Nguyen, A. H., Latkin, C. A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118185 · Cited by 45
Noninfectious Pulmonary Complications of Human Immunodeficiency Virus Infection
Staitieh, B. S., & Guidot, D. M. (2014) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000318 · Cited by 44
Metadata
- Authors
- Helleberg, M., Afzal, S., Kronborg, G., Larsen, C. S., Pedersen, G., Pedersen, C., Gerstoft, J., Nordestgaard, B. G., & Obel, N.
- Affiliations
- University of Copenhagen (DK)
- Herlev Hospital (DK)
- Hvidovre Hospital (DK)
- Aarhus University Hospital (DK)
- Aalborg University Hospital (DK)
- Odense University Hospital (DK)
- Copenhagen University Hospital (DK)
- Corresponding author
- Helleberg, Marie
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-12-18
- Volume
- 56
- Issue
- 5
- Pages
- 727-734
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2102073909
- Semantic Scholar
- 0934719904eec7f68660bcf4f44de59e533a4220
- Cited by
- 463
- References
- 33
- Citations by year
- 2026: 17 · 2025: 19 · 2024: 30 · 2023: 12 · 2022: 19 · 2021: 44 · 2020: 42 · 2019: 40 · 2018: 37 · 2017: 45 · 2016: 47 · 2015: 37 · 2014: 44 · 2013: 28 · 2012: 1
- FWCI
- 23.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Keywords
- smoking, HIV-1 infection, mortality, attributable mortality, non-AIDS-related mortality, life expectancy, years of life lost, population attributable risk, tobacco use, antiretroviral therapy
- MeSH terms
- Adult, Cause of Death, Denmark, Female, Humans, Life Expectancy, Male, Middle Aged, Risk Factors, Smoking, Cohort Studies, HIV-1, HIV Infections, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.